Corona: Natco joins Columbia University trials

After becoming part of a global clinical trial using Chloroquine Phosphate by CROWN (Covid-19 Research Outcomes Worldwide Network) Collaborative at the Washington University School of Medicine in St Louis, Hyderabad-based Natco Pharma Ltd has now joined a study by New York’s Columbia University to carry out Phase-2 clinical trials using Chloroquine Phosphate to prevent symptomatic SARS-CoV-2 infections.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *